CLINICAL_TRIALS
trial_result
· 2025-11-21
Clinical Trial Update: Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy
Summary
Completed clinical trial evaluating whether postoperative parathyroid hormone dosing can predict hypoparathyroidism after total thyroidectomy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Hypoparathyroidism | Status: COMPLETED